Levoplant Use In Pregnancy & Lactation

Pregnancy: The implants must be removed if pregnancy occurs during the use of Levonorgestrel (Levoplant). Animal studies have shown that very high doses of progestogenic substances may cause masculinization of female fetuses. The results of most epidemiological studies to date with relevant inadvertent fetal exposure to combinations of estrogens and progestogens indicate no teratogenic or fetotoxic effect. No studies are available on the effect of Levonorgestrel (Levoplant) during or prior to pregnancy.
Lactation: Levonorgestrel passes over into milk but epidemiological studies to date have not revealed serious adverse effects on the child. Studies have not shown any significant effects on the growth or other development of breast-fed babies whose mothers used other levonorgestrel implants from the sixth week after childbirth. Levels of levonorgestrel obtained with implants do not affect the quality or quantity of breast milk. However, it is not known if levonorgestrel is found in breast milk in the first 6 weeks after giving birth.
Fertility: The usual level of fertility will return after the implants are removed.